• 1

    Teigland JC, Tjonnfjord GE, Evensen SA, et al: Knee arthroplasty in hemophilia 5-12 year follow-up of 15 patients. .Acta Orthop Scand 64::153. ,1993. .

  • 2

    Arnold WD, Hilgartner MW: Hemophilic arthropathy: current concepts of pathogenesis and management. .J Bone Joint Surg Am 59::287. ,1977. .

  • 3

    Horoszowski H, Heim M, Schulman S, et al: Multiple joint procedures in a single operative session on hemophilic patients. .Clin Orthop 328::60. ,1996. .

  • 4

    Duthie RB, Dodd CAF: “Chronic Haemophilic Arthropathy,” in The Management of Musculo-skeletal Problems in the Haemophilias, 2nd Ed, ed by RB Duthie, CR Rizza, PLF Giangrande, et al, p 159, Oxford University Press, New York, 1994..

    • PubMed
    • Export Citation
  • 5

    Horoszowski H, Heim M, Seligsohn U, et al: “Use of the Laser Scalpel in Orthopaedic Surgery on Haemophilic Patients,” in Haemophilia, ed by U Seligsohn, A Rimon, H Horoszowski, p 189, Castle House Publishing Ltd, Turnbridge Wells, UK, 1981..

    • PubMed
    • Export Citation
  • 6

    Ragni MV, Crossett LS, Herndon JH: Postoperative infection following orthopaedic surgery in human immunodeficiency virus: infected hemophiliacs with CD4 counts ≤ 200/mm3. .J Arthroplasty 10::716. ,1995. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Levine PH: “Clinical Manifestations and Therapy of Hemophilias A and B,” in Hemostasis and Thrombosis: Basic Principles and Clinical Practice, ed by RW Coleman, J Hirsh, VJ Marder, et al, p 67, JB Lippincott, Philadelphia, 1982..

    • PubMed
    • Export Citation
  • 8

    Greene WB: Synovectomy of the ankle for hemophilic arthropathy. .J Bone Joint Surg Am 76::812. ,1994. .

  • 9

    Fabry G: Early biochemical and histological findings in experimental hemarthrosis in dogs. .Arch Orthop Trauma Surg 100::167. ,1982. .

  • 10

    Mainardi CL, Levine PH, Werb Z, et al: Proliferative synovitis in hemophilia: biochemical and morphologic observations. .Arthritis Rheum 21::137. ,1978. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Canale ST, Dugdale M, Howard BC: Synovectomy of the knee in young patients with hemophilia. .South Med J 81::1480. ,1988. .

  • 12

    Casscells CD: Commentary: the argument for early arthroscopic synovectomy in patients with severe hemophilia. .Arthroscopy 3::78. ,1987. .

  • 13

    Clark MW: Knee synovectomy in hemophilia. .Orthopedics 1::285. ,1978. .

  • 14

    DeGnore LT, Wilson FC: Surgical management of hemophilic arthropathy. .Instr Course Lect 38::383. ,1989. .

  • 15

    Wiedel JD: Arthroscopic synovectomy of the knee in hemophilia: 10-to-15 year followup. .Clin Orthop 328::46. ,1996. .

  • 16

    Bussi L, Silvello L, Baudo F, et al: Results of synovectomy of the knee in haemophilia. .Haematolgica 59::81. ,1974. .

  • 17

    Shopnick RI, Brettler DB: Hemostasis: a clinical review of conservative and operative care. .Clin Orthop 328::34. ,1996. .

  • 18

    Lofqvist T, Sanzen L, Petersson C, et al: Total hip replacement in patients with hemophilia: 13 hips in 11 patients followed for 1-16 years. .Acta Orthop Scand 67::321. ,1996. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Pearce MS, Smith MA, Savidge GF: Supramalleolar tibial osteotomy for haemophilic arthropathy of the ankle. .J Bone and Joint Surg Br 76::947. ,1994. .

  • 20

    Atkins RM, Henderson NJ, Duthie RB: Joint contractures in the hemophilias. .Clin Orthop 219::97. ,1987. .

  • 21

    Houghton GR, Dickson RA: Lower limb arthrodeses in haemophilia. .J Bone Joint Surg Br 60::387. ,1978. .

  • 22

    Luck JV Jr: Surgical management of advanced hemophilic arthropathy. .Prog Clin Biol Res 324::241. ,1990. .

  • 23

    Smith MA, Urquhart DR, Savidge GF: The surgical management of varus deformity in haemophilic arthropathy of the knee. .J Bone Joint Surg Br 63::261. ,1981. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Dyszy-Laube B, Kaminski W, Gizycka I, et al: Synovectomy in the treatment of hemophilic arthropathy. .J Pediatr Surg 9::123. ,1974. .

  • 25

    Gamba G, Grignani G, Ascari E: Synoviorthesis versus synovectomy in the treatment of recurrent haemophilic haemarthrosis: long-term evaluation. .Thromb Haemost 45::127. ,1981. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    van den Berg HM, Nieuwenhuis K, Mauser-bunschoten EP, et al: Hemophilia prophylaxis in the Netherlands. .Semin Hematol 31::13. ,1994. .

  • 27

    Steven MM, Small M, Pinkerton L, et al: Non-steroidal anti-inflammatory drugs in haemophilic arthritis: a clinical and laboratory study. .Haemostasis 15::204. ,1985. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Lofqvist T, Nilsson IM, Petersson C: Orthopaedic surgery in hemophilia: 20 years’ experience in Sweden. .Clin Orthop 332::232. ,1996. .

  • 29

    Rodriguez Merchan EC, Magallon M, Galindo E: Joint debridement for haemophilic arthropathy of the knee. .Int Orthop 18::135. ,1994. .

  • 30

    Ahlberg A: Treatment and prophylaxis of arthropathy in severe hemophilia. .Clin Orthop 53::135. ,1967. .

  • 31

    Brettler DB, Levine PH: Factor concentrates for treatment of hemophilia: which one to choose. ?Blood 73::2067. ,1989. .

  • 32

    Scharf R, Kucharski W, Nowak T: Surgery in hemophilia A patients with factor VIII inhibitor: 10-year experience. .World J Surg 20::1171. ,1996. .

  • 33

    O’Marcaigh AS, Schmalz BJ, Shaughnessy WJ, et al: Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor. .Mayo Clin Proc 69::641. ,1994. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Teigland JC, Tjonnfjord GE, Evensen SA, et al: Synovectomy for haemophilic arthropathy: 6-21 years of follow-up in 16 patients. .J Intern Med 235::239. ,1994. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Nilsson IM, Berntorp E, Ljung R, et al: Prophylactic treatment of severe hemophilia A and B can prevent joint disability. .Semin Hematol 31::5. ,1994. .

  • 36

    Aronstam A, Browne RS, Wassef M, et al: Clinical features of early haemarthoses in severely affected adolescent haemophiliacs. .Clin Lab Haematol 6::9. ,1984. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Greene WB, McMillan CW: Nonsurgical management of hemophilic arthropathy. .Instr Course Lect 38::367. ,1989. .

  • 38

    Wilson FC, Mahew DE, McMillan CW: Surgical management of musculoskeletal problems in hemophilia. .Instr Course Lect 32::233. ,1983. .

  • 39

    McMillan CW, Greene WB, Blatt PM, et al: The management of musculoskeletal problems in hemophilia. Part I: principles of medical management of hemophilia. .Instr Course Lect 32::210. ,1983. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Unger AS, Kessler CM, Lewis RJ: Total knee arthroplasty in human imunodeficiency virus–infected hemophiliacs. .J Arthroplasty 10::448. ,1995. .

  • 41

    Goedert JJ, Kessler CM, Aledort LM, et al: A prospective study of human immunodeficiency virus type I infection and the development of AIDS in subjects with hemophilia. .N Engl J Med 321::1141. ,1989. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    Greene WB, DeGore LT, White GC: Orthopaedic procedures and prognosis in hemophilic patients who are seropositive for human immunodeficiency virus. .J Bone Joint Surg Am 72::2. ,1990. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Brettler DB, Forsberg AD, Levine PH, et al: The use of porcine factor VIII (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. .Arch Intern Med 149::1381. ,1989. .

    • PubMed
    • Search Google Scholar
  • Brown DC: Adverse events reported in association with the use of monoclonal antibody purified factor VIIIC: monoclate. .Semin Hematol 27::16. ,1990. .

    • PubMed
    • Search Google Scholar
  • Gatti L, Mannucci PM: Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies. .Thromb Haemost 51::379. ,1984. .

    • PubMed
    • Search Google Scholar
  • Goldsmith JC, Gordon EM: Treatment of hemophilia B: serendipitous use of continuous infusion coagulation factor IX. .Thromb Res 70::265. ,1993. .

    • PubMed
    • Search Google Scholar
  • Hedner U: Factor VIIa in the treatment of haemophilia. .Blood Coagul Fibrinolysis 1::307. ,1990. .

    • PubMed
    • Search Google Scholar
  • Hedner U, Feldstedt M, Glazer S: “Recombinant FVIIa in Hemophilia Treatment,” in Hemophilia and von Willebrand’s Disease in the 1990s: Proceedings of the XIX Congress of the World Federation of Hemophilia, Washington, DC, August 14–19, 1990, ed by JM Lusher, CM Kessler, p 283, Elsevier Science, New York, 1991..

    • PubMed
  • Kasper CK: Treatment of factor VIII inhibitors. .Prog Hemost Thromb 9::57. ,1989. .

  • Kasper CK: Complications of hemophilia A treatment: factor VIII inhibitors. .Ann N Y Acad Sci 614::97. ,1991. .

    • PubMed
    • Search Google Scholar
  • Lethagen S, Egervall K, Berntorp E, et al: The administration of desmopressin by nasal spray: a dose-determination study in patients with mild hemophilia A or von Willebrand’s disease. .Haemophilia 1::97. ,1995. .

    • PubMed
    • Search Google Scholar
  • Lusher JM, Shapiro SS, Palascak JE, et al: Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. .N Engl J Med 303::421. ,1980. .

    • PubMed
    • Search Google Scholar
  • Mannucci PM: Desmopressin (DDAVP) for treatment of disorders of hemostasis. .Prog Hemost Thromb 8::19. ,1986. .

    • PubMed
    • Search Google Scholar
  • Mannucci PM, Bettaga D, Cattaneo M: Patterns development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). .Br J Haematol 82::87. ,1992. .

    • PubMed
    • Search Google Scholar
  • Mariani G, Scheibel E, Nagao T, et al: Immunotolerance as treatment of alloantibodies to factor VIII in hemophilia. .Emin Hematol (suppl) 31::62. ,1994. .

    • PubMed
    • Search Google Scholar
  • Nilsson IM: Factor VIII inhibitor treatment: immune tolerance. .Semin Hematol 31 (suppl 4)::44. ,1994. .

    • PubMed
    • Search Google Scholar
  • Nilsson IM, Berntorp E, Freiburghaus C: Treatment of patients with factor VIII and IX inhibitors. .Thromb Haemost 70::56. ,1993. .

    • PubMed
    • Search Google Scholar
  • Nilsson IM, Berntorp E, Zettervall O: Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII. .N Engl J Med 318::947. ,1988. .

    • PubMed
    • Search Google Scholar
  • Petrini P, Lindvall N, Egberg N, et al: Prophylaxis with factor concentrates in preventing hemophilic arthropathy. .Am J Pediatr Hematol Oncol 13::280. ,1991. .

    • PubMed
    • Search Google Scholar
  • Ragni MV, Hanley EN: Septic arthritis in hemophilic patients and infection with human immunodeficiency virus (HIV). .Ann Intern Med 110::168. ,1989. .

    • PubMed
    • Search Google Scholar
  • Rudowski WJ, Scharf R, Ziemski JM: Is major surgery in hemophiliac patients safe. ?World J Surg 11::378. ,1987. .

    • PubMed
    • Search Google Scholar
  • Seremetis SV: The clinical use of factor VIIa in the treatment of factor VIII inhibitor patients. .Semin Haemtol 31 (suppl)::53. ,1994. .

    • PubMed
    • Search Google Scholar
  • Soreff J: Joint debridement in the treatment of advanced hemophilic knee arthropathy. .Clin Orthop 191::179. ,1984. .

    • PubMed
    • Search Google Scholar
  • Weber DJ, Becherer PR, Rutala WA, et al: Nosocomial infection rate as a function of human immunodeficiency virus type I status in hemophiliacs. .Am J Med (suppl) 91::206. ,1991. .

    • PubMed
    • Search Google Scholar

Hemophilic Arthropathy: Considerations in Management

Thomas J. Chang Clinical Professor and Immediate Past Chairman, California College of Podiatric Medicine; private practice San Francisco and Santa Rosa, CA. Mailing address:2281 Cleveland Ave, Santa Rosa, CA 95403.

Search for other papers by Thomas J. Chang in
Current site
Google Scholar
PubMed
Close
 DPM
,
Shenin Mohamed Submitted during second-year residency, Memorial Hospital of Rhode Island, Brown University, Pawtucket, RI.

Search for other papers by Shenin Mohamed in
Current site
Google Scholar
PubMed
Close
 BSc(Pharm), DPM
, and
Julie Hambleton Associate Clinical Professor, University of California, San Francisco School of Medicine, San Francisco, CA.

Search for other papers by Julie Hambleton in
Current site
Google Scholar
PubMed
Close
 MD

The authors evaluate nonsurgical and surgical approaches to treating patients with hemophilic arthropathy and review the functional and economic limitations imposed on treating these patients. Indications for surgery are discussed and a case study that incorporates both conservative and surgical management options is presented. While the advent of factor replacement therapy has dramatically changed the course of treatment and prognosis for patients with hemophilia, the authors argue that the economic burden of treating these patients is still very high. The authors recommend that proper conservative and surgical management options for patients with hemophilia should be based upon a thorough understanding of the disease process. (J Am Podiatr Med Assoc 91(8): 406-414, 2001)

Save